SOD2 and cancer: Clair group has delineated the role of p53 in SOD2 regulation in cancer and importantly demonstrated potential mechanisms for the biphasic expression of SOD2 observed during tumor initiation and tumor progression, which are characterized by low SOD2 and high SOD2 expression, respectively.